Home

Justin B. Klee, Co-CEO: Amylyx Pharmaceuticals AMLX Sell · Filed 25/01/08

Trade details

Type
Insider sale
Amount
$30,182.84
Shares · price
7,471 sh · $4.04 a share
Held after
3,176,788 sh
Trade date
25/01/06
Filed
25/01/08
Days to filing
2 days

Sold 0.2% of holdings

Share of holding sold
0.2%

Amylyx Pharmaceuticals trades, last 26 weeks

What else happened in Amylyx Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 24/12/07~25/02/05

Justin B. Klee's recent trades

  • Justin B. Klee

    Planned saleAmylyx Pharmaceuticals

    $980.3K

    Filed 09/11

  • Justin B. Klee

    SellAmylyx Pharmaceuticals

    $423.7K

    Filed 03/04

  • Justin B. Klee

    Planned saleAmylyx Pharmaceuticals

    $423.8K

    Filed 03/02

  • Justin B. Klee

    SellAmylyx Pharmaceuticals

    $227.7K

    Filed 02/04

  • Justin B. Klee

    Planned saleAmylyx Pharmaceuticals

    $227.6K

    Filed 02/02

Justin B. Klee, CEO — sold $30.2K of Amylyx Pharmaceuticals AMLX · 0.2% of holdings | Whalegun